Jim Simons Novartis Ag Transaction History
Renaissance Technologies LLC
- $63.1 Billion
- Q3 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novartis Ag stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,300,678 shares of NVS stock, worth $227 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
2,300,678
Previous 2,499,782
7.96%
Holding current value
$227 Million
Previous $266 Million
0.56%
% of portfolio
0.42%
Previous 0.47%
Shares
24 transactions
Others Institutions Holding NVS
# of Institutions
1,437Shares Held
131MCall Options Held
1.12MPut Options Held
1.83M-
Dodge & Cox San Francisco, CA12.2MShares$1.2 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA12MShares$1.18 Billion1.03% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$797 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$688 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$568 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $212B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...